Study: Lannuzel 2008, Movement Disorders
Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacin
Citation
Lannuzel A, Ruberg M, Michel PP (2008). Movement Disorders. PubMed id 18816693.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Soursop (graviola): cancer cure, blood sugar and safety Tier D
B Patients with atypical parkinsonism on Guadeloupe; midbrain cell cultures; rats (n=not stated in the abstract)
Epidemiological association plus lab and animal experiments (review of the programme).
On Guadeloupe atypical parkinsonian patients were two-thirds of all parkinsonism cases, against about 5% in European data. Epidemiological data suggested a close association with regular consumption of soursop. Annonacin, a mitochondrial complex I inhibitor in the fruit and leaves, was identified in cell cultures as a probable cause, and giving it to rats reproduced the brain lesions.
As recorded in this card: Lannuzel A, Ruberg M, Michel PP (2008), Movement Disorders, [review]
Note: Review by authors of the original work. MSK notes it is unclear whether the neurotoxicity translates to humans, and one review reports a favourable profile for leaf extract.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.